Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 4/2020

28.08.2020 | short review

Transoral robotic surgery in head and neck cancer

verfasst von: Andreas Strobl, Maximilian Hartl, Martin Burian

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Robotic surgery in the field of head and neck cancer was initiated at the beginning of this century. In the last decade, transoral robotic surgery (TORS) had to prove its oncological equivalence to standardised conservative treatment regimens like radiotherapy and radiochemotherapy and to other transoral or open surgical procedures. The amount of data on oncological efficacy, cost effectiveness and long-term outcomes has continued to increase over the last few years. The transoral approach enables minimally invasive tumour resection, which helps to minimize functional postoperative deficits. Compared with traditional concurrent radiochemotherapy (CRCT), the radiation dose is lower in the adjuvant setting and therefore helps to reduce long-term toxicities. Moreover, in case of absent risk factors in the histological specimen, it might be possible to avoid additional chemotherapy. Thus, long-term toxicities eventually caused by CRCT might be decreased.
Literatur
1.
Zurück zum Zitat O’Malley BW Jr, Weinstein GS, Snyder W, et al. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope. 2006;116(8):1465–72. CrossRef O’Malley BW Jr, Weinstein GS, Snyder W, et al. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope. 2006;116(8):1465–72. CrossRef
2.
Zurück zum Zitat Steiner W. Experience in endoscopic laser surgery of malignant tumours of the upper aero-digestive tract. Adv Oto-Rhino-Laryngol. 1988;39:135–44. CrossRef Steiner W. Experience in endoscopic laser surgery of malignant tumours of the upper aero-digestive tract. Adv Oto-Rhino-Laryngol. 1988;39:135–44. CrossRef
3.
Zurück zum Zitat Canis M, Martin A, Kron M, et al. Results of transoral laser microsurgery in 102 patients with squamous cell carcinoma of the tonsil. Eur Arch Otorhinolaryngol. 2013;270(8):2299–306. CrossRef Canis M, Martin A, Kron M, et al. Results of transoral laser microsurgery in 102 patients with squamous cell carcinoma of the tonsil. Eur Arch Otorhinolaryngol. 2013;270(8):2299–306. CrossRef
4.
Zurück zum Zitat Canis M, Martin A, Ihler F, et al. Results of transoral laser microsurgery for supraglottic carcinoma in 277 patients. Eur Arch Otorhinolaryngol. 2013;270(8):2315–26. CrossRef Canis M, Martin A, Ihler F, et al. Results of transoral laser microsurgery for supraglottic carcinoma in 277 patients. Eur Arch Otorhinolaryngol. 2013;270(8):2315–26. CrossRef
5.
Zurück zum Zitat Pignon JP, le Maitre A, Maillard E, MACH-NC Collaborative Group, MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92(1):4–14. CrossRef Pignon JP, le Maitre A, Maillard E, MACH-NC Collaborative Group, MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92(1):4–14. CrossRef
6.
Zurück zum Zitat Steiner W. Endoskopische Laserchirurgie der oberen Luft- und Speisewege. Schwerpunkt Tumorchirurgie. Stuttgart New York: Thieme; 1997. Steiner W. Endoskopische Laserchirurgie der oberen Luft- und Speisewege. Schwerpunkt Tumorchirurgie. Stuttgart New York: Thieme; 1997.
7.
Zurück zum Zitat Nichols AC, Theurer J, Prisman E, et al. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. Lancet Oncol. 2019;20(10):1349–59. CrossRef Nichols AC, Theurer J, Prisman E, et al. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. Lancet Oncol. 2019;20(10):1349–59. CrossRef
8.
Zurück zum Zitat Sethia R, Yumusakhuylu AC, Ozbay I, et al. Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer. Laryngoscope. 2018;128(2):403–11. CrossRef Sethia R, Yumusakhuylu AC, Ozbay I, et al. Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer. Laryngoscope. 2018;128(2):403–11. CrossRef
9.
Zurück zum Zitat Castellano A, Sharma A. Systematic review of validated quality of life and swallow outcomes after transoral robotic surgery. Otolaryngol Head Neck Surg. 2019;161(4):561–7. CrossRef Castellano A, Sharma A. Systematic review of validated quality of life and swallow outcomes after transoral robotic surgery. Otolaryngol Head Neck Surg. 2019;161(4):561–7. CrossRef
10.
Zurück zum Zitat Choby GW, Kim J, Ling DC, et al. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes. JAMA Otolaryngol Head Neck Surg. 2015;141(6):499–504. CrossRef Choby GW, Kim J, Ling DC, et al. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes. JAMA Otolaryngol Head Neck Surg. 2015;141(6):499–504. CrossRef
11.
Zurück zum Zitat Dawe N, Patterson J, O’Hara J. Functional swallowing outcomes following treatment for oropharyngeal carcinoma: a systematic review of the evidence comparing trans-oral surgery versus non-surgical management. Clin Otolaryngol. 2016;41(4):371–85. CrossRef Dawe N, Patterson J, O’Hara J. Functional swallowing outcomes following treatment for oropharyngeal carcinoma: a systematic review of the evidence comparing trans-oral surgery versus non-surgical management. Clin Otolaryngol. 2016;41(4):371–85. CrossRef
12.
Zurück zum Zitat Hatten KM, O’Malley BW Jr, Bur AM, et al. Transoral robotic surgery-assisted endoscopy with primary site detection and treatment in occult mucosal primaries. JAMA Otolaryngol Head Neck Surg. 2017;143(3):267–73. CrossRef Hatten KM, O’Malley BW Jr, Bur AM, et al. Transoral robotic surgery-assisted endoscopy with primary site detection and treatment in occult mucosal primaries. JAMA Otolaryngol Head Neck Surg. 2017;143(3):267–73. CrossRef
13.
Zurück zum Zitat Byrd JK, Smith KJ, de Almeida J, et al. Transoral robotic surgery and the unknown primary: a cost-effectiveness analysis. Otolaryngol Head Neck Surg. 2014;150(6):976–82. CrossRef Byrd JK, Smith KJ, de Almeida J, et al. Transoral robotic surgery and the unknown primary: a cost-effectiveness analysis. Otolaryngol Head Neck Surg. 2014;150(6):976–82. CrossRef
14.
Zurück zum Zitat Winter SC, Ofo E, Meikle D, et al. Trans-oral robotic assisted tongue base mucosectomy for investigation of cancer of unknown primary in the head and neck region. The UK experience. Clin Otolaryngol. 2017;42(6):1247–51. CrossRef Winter SC, Ofo E, Meikle D, et al. Trans-oral robotic assisted tongue base mucosectomy for investigation of cancer of unknown primary in the head and neck region. The UK experience. Clin Otolaryngol. 2017;42(6):1247–51. CrossRef
16.
Zurück zum Zitat Orosco RK, Arora A, Jeannon JP, et al. Next-Generation Robotic Head and Neck Surgery. J Oto-rhino-laryngology. 2018;80(3):213–9. Orosco RK, Arora A, Jeannon JP, et al. Next-Generation Robotic Head and Neck Surgery. J Oto-rhino-laryngology. 2018;80(3):213–9.
17.
Zurück zum Zitat Spellman J, Coulter M, Kawatkar A, et al. Comparative cost of transoral robotic surgery and radiotherapy (IMRT) in early stage tonsil cancer. Am J Otolaryngol. 2020;102409. Spellman J, Coulter M, Kawatkar A, et al. Comparative cost of transoral robotic surgery and radiotherapy (IMRT) in early stage tonsil cancer. Am J Otolaryngol. 2020;102409.
Metadaten
Titel
Transoral robotic surgery in head and neck cancer
verfasst von
Andreas Strobl
Maximilian Hartl
Martin Burian
Publikationsdatum
28.08.2020
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 4/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-020-00638-5